Jane Chung - 10 Aug 2022 Form 3 Insider Report for Viracta Therapeutics, Inc. (VIRX)

Role
Director
Signature
/s/ Daniel Chevallard, as Attorney-in-Fact
Issuer symbol
VIRX
Transactions as of
10 Aug 2022
Net transactions value
$0
Form type
3
Filing time
11 Aug 2022, 18:47:43 UTC
Previous filing
10 Aug 2022
Next filing
07 Mar 2023

No securities are beneficially owned.

Remarks:

No securities beneficially held.